91 related articles for article (PubMed ID: 19661353)
1. Effect of aromatase inhibitors on lipid metabolism, inflammatory response and antioxidant balance in patients with breast carcinoma.
Melichar B; Kalábová H; Krcmová L; Urbánek L; Hyspler R; Solichová D; Melicharová K; Pecka M; Zadák Z
Anticancer Res; 2009 Aug; 29(8):3337-46. PubMed ID: 19661353
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte alpha-tocopherol in breast cancer patients treated with letrozol.
Melichar B; Plísek J; Hyspler R; Kalábová H; Kasparová M; Krcmová L; Studentová H; Solichová D
J Nutr Sci Vitaminol (Tokyo); 2010; 56(2):98-103. PubMed ID: 20495290
[TBL] [Abstract][Full Text] [Related]
3. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
[TBL] [Abstract][Full Text] [Related]
4. Serum alpha-tocopherol, retinol and neopterin during paclitaxel/carboplatin chemotherapy.
Melichar B; Kalábová H; Krcmová L; Urbánek L; Hyspler R; Malírova E; Solichová D
Anticancer Res; 2007; 27(6C):4397-401. PubMed ID: 18214051
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitors and the endometrium.
Cohen I
Maturitas; 2008 Apr; 59(4):285-92. PubMed ID: 18448280
[TBL] [Abstract][Full Text] [Related]
6. The effect of aromatase inhibitors on bone metabolism.
Folkestad L; Bjarnason NH; Bjerregaard JK; Brixen K
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):3-10. PubMed ID: 19152547
[TBL] [Abstract][Full Text] [Related]
7. Effects of hormonal treatment on lipids in patients with cancer.
Filippatos TD; Liberopoulos EN; Pavlidis N; Elisaf MS; Mikhailidis DP
Cancer Treat Rev; 2009 Apr; 35(2):175-84. PubMed ID: 19013720
[TBL] [Abstract][Full Text] [Related]
8. Effect of the potent aromatase inhibitor fadrozole hydrochloride (CGS 16949A) in postmenopausal women with breast carcinoma.
Costa LA; Kopreski MS; Demers LM; Chinchilli VM; Santen RJ; Harvey HA; Lipton A
Cancer; 1999 Jan; 85(1):100-3. PubMed ID: 9921980
[TBL] [Abstract][Full Text] [Related]
9. Very low density lipoprotein and low density lipoprotein isolated from patients with hepatitis C infection induce altered cellular lipid metabolism.
Napolitano M; Giuliani A; Alonzi T; Mancone C; D'Offizi G; Tripodi M; Bravo E
J Med Virol; 2007 Mar; 79(3):254-8. PubMed ID: 17245726
[TBL] [Abstract][Full Text] [Related]
10. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
Morales L; Pans S; Verschueren K; Van Calster B; Paridaens R; Westhovens R; Timmerman D; De Smet L; Vergote I; Christiaens MR; Neven P
J Clin Oncol; 2008 Jul; 26(19):3147-52. PubMed ID: 18474874
[TBL] [Abstract][Full Text] [Related]
11. The potential adverse effects of aromatase inhibitors on wound healing: in vitro and in vivo evidence.
Howgate DJ; Gamie Z; Panteliadis P; Bhalla A; Mantalaris A; Tsiridis E
Expert Opin Drug Saf; 2009 Sep; 8(5):523-35. PubMed ID: 19645634
[TBL] [Abstract][Full Text] [Related]
12. [Hormonal therapy with aromatase inhibitor in advanced breast cancer].
Vrbanec D; Belev B; Pavlinić-Diminić V; Pezerović D; Dusper B; Plestina S; Unusić J
Lijec Vjesn; 1998; 120(10-11):315-8. PubMed ID: 19658346
[TBL] [Abstract][Full Text] [Related]
13. Vitamin C-lipid metabolites: uptake and retention and effect on plasma C-reactive protein and oxidized LDL levels in healthy volunteers.
Pancorbo D; Vazquez C; Fletcher MA
Med Sci Monit; 2008 Nov; 14(11):CR547-51. PubMed ID: 18971870
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serum retinol, serum alpha-tocopherol, and urinary neopterin in patients with head and neck carcinoma treated with external beam radiation.
Holečková P; Krčmová L; Kalábová H; Kašparová M; Plíšek J; Pála M; Vítek P; Solichová D; Zezulová M; Studentová H; Melichar B
Int J Vitam Nutr Res; 2012 Apr; 82(2):77-84. PubMed ID: 23065832
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of aromatase inhibitors' side effects in clinical and experimental studies].
Kubatka P; Péc M
Klin Onkol; 2009; 22(3):89-93. PubMed ID: 19708541
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors].
Ohtake T; Yasuda M; Watanabe K; Ito T; Ito J; Miyamoto K; Yoshida S; Abe N; Ishigame T; Ishii M; Kimijima I; Takenoshita S
Gan To Kagaku Ryoho; 2009 Sep; 36(9):1459-63. PubMed ID: 19755813
[TBL] [Abstract][Full Text] [Related]
17. [Overview of lipoprotein and lipids].
Yamada N
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):7-10. PubMed ID: 9644994
[No Abstract] [Full Text] [Related]
18. [A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy].
Baba S; Oji Y; Teramoto M; Kawabata K; Saito A
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1905-6. PubMed ID: 19920398
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors in breast cancer.
Hiscox S; Davies EL; Barrett-Lee P
Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein: binding to lipids and lipoproteins.
Pepys MB; Rowe IF; Baltz ML
Int Rev Exp Pathol; 1985; 27():83-111. PubMed ID: 3915746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
